Exosome Exotherapy: Lior Shaltiel on a Platform for CNS Regeneration
Today, we sit down with Dr. Lior Shaltiel of NurExone Biologics to explore how exosome-based delivery of siRNA could...
First Pharma to Restore Sense of Smell? Inside the FLAVOR Trial Quest to Treat Postviral Olfactory Loss
In this interview, I’m talking with Rick Geoffrion, Founder, President, and CEO of Cyrano Therapeutics, about FLAVOR, a Phase...
Shining Light on Women’s Health: A New Non-Drug Vaginal Therapy
In this interview, I spoke with Dr. Melanie Santos, Chief Medical Officer at Cern Corporation, about a novel low...
The Human Cost of Fragmented Technology: A Conversation with Veeva’s Bree Burks
At the Veeva R&D and Quality Summit in Boston, we spoke with Bree Burks, Vice President of Strategy at...
Dye-Driven Precision: Targeting Chemo Directly to Tumors
Lyle Small leads a biotech startup pursuing a bold new approach: dye-drug conjugates that carry chemotherapy directly to cancer...
Northwell Christina Brennan on Future of Site-Sponsor Partnerships
At the Veeva R&D and Quality Summit in Boston, we interviewed Dr. Christina Brennan, Senior Vice President of Clinical...
AI’s Transformative Role in Colorectal Cancer Screening
In the dynamic field of gastroenterology, AI is revolutionizing clinical practices, particularly in colorectal cancer screening. Dror Zur, CEO...
Redefining Imaging Workflows in Clinical Trials
At the Veeva R&D and Quality Summit in Boston, Moe Alsumidaie interviewed Jeff Sorenson, CEO of Yunu, and Steve...
What Clinical Trial Venture Capital Think About Clinical Trial Tech
“Even when the ROI is 10 to 13x, it still takes six years to adopt.” That’s the paradox that...
Pharma Cuts Clinical Trial CSR Time by >50% With AI
AI is revolutionizing clinical documentation in clinical trials. In this interview, Anita Modi, CEO and Founder of Peer AI,...